Allergy

LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis
Zhangfu Fang, Fagui Chen, Fang Yi, Huasi Zhao, Chuqin Huang, Chenhui Li, Jiaxing Xie, Kefang Lai, Nanshan Zhong

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3541; DOI: 10.1183/13993003.congress-2016.OA3541
Age at allergic sensitization is strongly related to asthma and rhinitis in young adulthood
Joakim Bunne, Linnea Hedman, Martin Andersson, Helena Backman, Bo Lundbäck, Eva Rönmark

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3321; DOI: 10.1183/13993003.congress-2016.OA3321
A child's spit epigenome can reveal its respiratory allergy risk
Sabine Langie, Matthieu Moisse, Katarzyna Szarc vel Szic, Ellen Van Der Plas, Gudrun Koppen, Guy Van Camp, Diether Lambrechts, Greet Schoeters, Wim Vanden Berghe, Patrick De Boever

European Respiratory Journal Sep 2016, 48 (suppl 60) OA3306; DOI: 10.1183/13993003.congress-2016.OA3306
Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy
Eric D. Bateman, Alfredo Guerreros, Florian Brockhaus, Bjoern Holzhauer, Abhijit Pethe, Richard Kay, Robert G. Townley

European Respiratory Journal Sep 2016, 48 (suppl 60) OA1981; DOI: 10.1183/13993003.congress-2016.OA1981
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker
Masayuki Takai, Junya Ono, Ayami Kamei, Hisako Matsumoto, Shoichiro Ohta, Kenji Izuhara

European Respiratory Journal Sep 2016, 48 (suppl 60) OA1980; DOI: 10.1183/13993003.congress-2016.OA1980
Serum Th2 cytokine profiles in mould sensitised adults from a large population-based cohort
Jeanette Reece, Rangi Kandane-Rathnayake, Mimi Tang, Julie Simpson, Iain Feather, Melissa Southey, John Hopper, Stephen Morrison, Graham Giles, EHaydn Walters, Shyamali Dharmage, Melanie Matheson

European Respiratory Journal Sep 2015, 46 (suppl 59) PA5093; DOI: 10.1183/13993003.congress-2015.PA5093
A PKPD mathematical model to determine efficacy of multiple doses of QGE031 (ligelizumab) vs. omalizumab and placebo in inhibiting skin responses in atopic asthmatics
P.J. Lowe, I. Bottoli, J. Arm, A. Skerjanec, A. Groenewegen, S. Maahs

European Respiratory Journal Sep 2015, 46 (suppl 59) PA5092; DOI: 10.1183/13993003.congress-2015.PA5092
QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study
Gail M. Gauvreau, Louis-Philippe Boulet, Richard Leigh, Donald W. Cockcroft, Beth E. Davis, Irvin Mayers, J. Mark FitzGerald, Barbro Dahlen, R.M. Watson, Joanne Milot, Veronica Swystun, Linda Hui, Ann-Sofie Lantz, Miranda Bowen, Jonathan Arm, Suzzane Maahs, Karin Meiser, Philip Lowe, Andrej Skerjanec, Christopher Carlsten, Karin Strandberg, Kieran J. Killian, Michele Laviolette, Anton Drollmann, Paul M. O'Byrne

European Respiratory Journal Sep 2015, 46 (suppl 59) PA5091; DOI: 10.1183/13993003.congress-2015.PA5091
Airway hyperresponsiveness (AHR) of small airways assessed by impulse oscillation (IOS) in adult asthma
Hisatoshi Hijikata, Masaya Takemura, Norihisa Takeda, Kensuke Fukumitsu, Hiroya Ichikawa, Takamitsu Asano, Takehiro Uemura, Osamu Takakuwa, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Atsushi Nakamura, Akio Niiimi

European Respiratory Journal Sep 2015, 46 (suppl 59) PA5083; DOI: 10.1183/13993003.congress-2015.PA5083
LATE-BREAKING ABSTRACT: Alveolar nitric oxide, small airway physiology and plasma biomarkers following inhaled allergen challenge in asthmatic subjects
Henning Svensson, Zuzana Diamant, Leif Bjermer, Ellen Tufvesson

European Respiratory Journal Sep 2015, 46 (suppl 59) PA5082; DOI: 10.1183/13993003.congress-2015.PA5082

Main menu

User menu

Search

Allergy

Pages

Contact us